Commentary
Video
Prognosis, Rarity of NRG1+ Pancreatic Cancer
Author(s):
E. Gabriela Chiorean, MD, of Fred Hutch Cancer Center, discusses prognosis and rarity of patients with NRG1 fusion–positive pancreatic cancer.
EP: 1.Prevalence of NRG1 Fusions in Lung Cancer
EP: 2.Differences Between DNA and RNA Testing for NRG1
EP: 3.Standard Treatments for NRG1 Fusion+ NSCLC
EP: 4.Ongoing Research Efforts Targeting NRG1 in Lung Cancer
EP: 5.Efficacy With NRG1-Directed Agents in NSCLC
Now Viewing
EP: 6.Prognosis, Rarity of NRG1+ Pancreatic Cancer
EP: 7.Choosing RNA Over DNA Testing for NRG1 Fusions in Pancreatic Cancer
EP: 8.Standard Treatment Regimens for NRG1+ Pancreatic Cancer
EP: 9.Poised Potential With Zenocutuzumab in NRG1+ Pancreatic Cancer
Related Videos
Related Content
